SEI partners with Cronimet to advance Tungsten project

Published 03-JAN-2019 10:03 A.M.

|

3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Speciality Metals International Limited (ASX:SEI) has taken another step in its plans to be a pre-eminent Australian tungsten producer from its historic Mt Carbine tungsten mine in Far North Queensland.

The company is in advanced negotiations to partner with one of the world’s leading mining and raw material supply companies, Cronimet Holding GmbH (CRONIMET) part of the Cronimet Group, which operates a global supply chain for stainless steel, specialty steel raw materials and other strategic minerals, and has significant expertise in the recovery of high-quality raw materials through latest technology and production methods.

The partnership with CRONIMET will assist with the acquisition of the Mt Carbine Quarry and Mining Leases and the development of its world class tungsten project.

The negotiations are for conditional participation for the staged development of Mt Carbine Tungsten Project and to enable the purchase of the Mt Carbine Quarry and Mining Leases (ML4867 & ML4919) by the company through alternative financial instruments.

CRONIMET will provide a cash advance of US$3.5 million (~A$4.9 million) by way of an off-take agreement defining the delivery of tungsten concentrate from the Mt Carbine Tungsten Project.

The Tailings Retreatment Plant will be recommissioned and production will commence from the ~12 million tonnes of stockpiled material. CRONIMET will provide the technical expertise and assist with the refurbishment of the existing Tailings Retreatment Plant as well as sourcing the plant that’s required to commence production from the stockpiled material.

Subject to further due diligence, the Tailings and Stockpile projects may be undertaken by a newly formed joint venture company where it is intended that SEI and CRONIMET will each hold a 50% stake. SEI will also be entitled to receive a 2.5% royalty on the gross revenue of the newly formed joint venture company.

It is anticipated that production lead times will be minimal as both projects are fully permitted. The management team for the quarry are already in place to ensure a seamless hand-over and the company expects to not only maintain but also build upon this segment’s earning potential.

The company is also in advanced discussions with CRONIMET and institutional investors on share placement opportunities. The proceeds from this share placement, together with the Cash Advance, will be used to complete the purchase of the Mt Carbine Quarry and Mining Leases, ML 4867 and ML 4919.

The parties are committed to finalising these arrangements within the shortest possible timeframe and are aiming to be in production by the end of the first half of 2019. In line with its staged development approach, SEI will also pursue the necessary permitting and approvals for its Open Pit Hard Rock Project.

After a lacklustre six months, the news was well received by SEI shareholders, who pushed the stock to a high of 20 cents per share on significant volume.

SEI 6-month chart

Executive Chairman of Speciality Metals, Mr Russell Krause stated:

“These are exciting times for the Company and its shareholders and the Board looks forward to working closely with Cronimet in realising the value of its Mt Carbine Tungsten Project.”

“The Board would also like to thank all shareholders for their patience and look forward to announcing the finalisation of the above financing arrangements early in the New Year.”

Whilst maintaining its world-class tungsten assets at Mt Carbine in Far North Queensland, which consist of the Mt Carbine Tungsten Mine and the Iron Duke and Petersens Lode Exploration Permits.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X